Pentraxin-3 Anti-Human 100 µg

In stock

Cat-Nr.
101-M605
Size
100 µg
  €533.00

Description / Pentraxin-3

Pentraxin 3 (PTX3), TSG14, was initially identified as a TNFα or IL1β inducible gene. It belongs to the pentraxin family, which was named originally for the homopentameric structure formed by its members. The pentraxin family is divided into two subfamilies: the “short” and the “long” pentraxins with approximate molecular weights of 25 kDa and 50 kDa, respectively. TSG14 is a member of the long pentraxin subfamily, which also includes the Xenopus laevis XLPXN1, the guinea pig apexin/p50, the rat neuronal pentraxin I (NPI) and NPR, the human neuronal pentraxin II (NPTX2) and the human neuronal activityrelated pentraxin. Mature secreted TSG14 contains a pentaxinlike domain at its carboxyterminus that shares 23-28% amino acid (aa) sequence similarity to Creactive protein (CRP) and serum amyloid P component (SAP), which belongs to the short pentraxin subfamily. However, the Nterminal sequence of TSG 14 does not share aa sequence homology with any of the “short” pentaxins. Unlike CRP and SAP, which forms pentamers only, TSG14 forms both pentameric and higher ordered oligomers. Similarly to CRP and SAP, TSG14 binds to the complement cascade component C1q. However, TSG14 does not bind to phosphoethanolamine, phosphocholine, or high pyruvate agarose, which are known ligands for CRP and SAP. TSG14 is a marker of the acute phase response and is highly expressed in advanced atherosclerotic plaques. While CRP and SAP are primarily produced in the liver, TSG14 expression is strongly upregulated by TNFα, IL1β, and bacterial LPS in peripheral fibroblasts, endothelial cells, and macrophages. At the amino acid level, human and mouse TSG14 share 88% aa sequence homology. TSG14 concentration is elevated in the joint fluid of patients with rheumatoid arthritis (RA), indicating that TSG14 may be a potential mediator of immune response. TSG14 may also function in the regulation of the uptake and clearance of apoptotic cells by dendritic cells. In vivo study showed that TSG14 transgenic mice are more resistant to sepsis and endotoxemia compared to wild type during the inflammatory injury. Increased expression of TSG14 may enhance the immune response to protect the host from infection.

More Information

Size 100 µg
Source Mouse
Isotype IgG2
Clone Nr. (#6B7)
Species Reactivity Human
Formulation lyophilized
Buffer PBS
Reconstitution Centrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
Stability and Storage Lyophilized samples are stable for 2 years from date of receipt when stored at -20°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity.
Preparation This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse) immunized with recombinant human Pentraxin-3, also called TSG-14.
Antigen recombinant human Pentraxin-3
Application WB
Synonyms PTX3; TSG-14; TNFAIP5
Uniprot ID P26022
Protein RefSeq NP_002843.2
mRNA RefSeq NM_002852.3

All prices plus VAT + possible delivery charges